Global Med Technologies(R) Appoints Veteran CFO, Karen Davis
November 17 2008 - 9:00AM
PR Newswire (US)
Extensive Experience in Public Companies, M&A, Financings and
IR DENVER, Nov. 17 /PRNewswire-FirstCall/ -- Global Med
Technologies(R), Inc. ("Global Med" or "the Company") (OTC:GLOB)
(BULLETIN BOARD: GLOB) , an international e-Health, medical
information technology company, today announced the appointment of
Karen Davis to the position of Chief Financial Officer. Ms. Davis
officially assumes the position of CFO today. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) Ms.
Davis brings to the Company her strong business drive and
diversified experience as a CFO. Her background includes a BS in
Business Administration from California State University, a CPA, 10
years in public accounting, and 15 years of CFO experience,
including 8 years with public companies. Ms. Davis also has broad
IR experience, having served 3 years as Director of Financial
Reporting and Investor Relations for an NYSE-listed company. In
addition, Ms. Davis has extensive M&A experience, as well as
experience in scaling companies through organic growth and
acquisition. Ms. Davis will report directly to Mick Ruxin, M.D.,
Chairman and Chief Executive Officer of Global Med Technologies,
Inc. In his comments about this key appointment, Dr. Ruxin stated,
"As a direct result of our dramatic growth into a leading global
entity in the blood supply safety arena, and our expansion into
other biomedical areas, the need for a CFO with extensive knowledge
in public accounting, mergers and acquisitions, sophisticated
financing and investor relations became mandatory. Such a highly
experienced senior executive will play a crucial role in attaining
our objectives of profitable, rapid growth and moving to a listed
exchange. I am extremely pleased to have an individual with the
knowledge and abilities tempered by the experience of Karen Davis
join our Company. Karen is a great fit for Global Med, and with her
background, she will truly add value to our strategy, our processes
and our management team." Commenting on her appointment, Ms. Davis
said, "I am very excited to join a dynamic growth company in a
global market." Ms. Davis continued, "Also, I am particularly
pleased to be a part of a creative management team that is truly
making a difference in the blood bank, hospital, laboratory and
biologic software industry throughout the world." About Global Med
Technologies, Inc. Global Med Technologies(R), Inc. is an
international medical software company which develops regulated and
non-regulated software products and services for the healthcare
industry. As a leading provider of blood and laboratory software
applications and services, Global Med's products are deployed in 20
countries and serve over 1,600 transfusion centers, blood banks and
laboratories. Global Med's U.S. division, Wyndgate Technologies(R),
provides Vein-to-Vein(R) tracking through its Donor Doc(TM),
SafeTrace(R), SafeTrace Tx(R) and ElDorado Donor(TM) software
products. Each year, Wyndgate's products and services manage more
than eight million blood components, representing over 27% of the
U.S. blood supply. Global Med's European subsidiary, Inlog, SA, is
a leading provider of donor center and transfusion management
systems as well as cellular therapy software, laboratory
information systems and quality assurance medical software systems
internationally. Inlog's products include EdgeBlood*, EdgeTrack*,
EdgeCell, EdgeLab and Sapa/SapaNet. Global Med's U.S. division,
eDonor(R), provides a web-based donor relationship management
system that integrates recruitment, scheduling, retention and
fulfillment for national as well as local community blood centers
and hospitals. eDonor's products and services are designed to
complement Global Med's strong line of international blood
management and laboratory information software and service
solutions. Global Med's U.S. subsidiary, PeopleMed(R), Inc.,
provides cost-effective customized software validation, consulting
and compliance solutions to hospitals and donor centers. For more
information about Global Med's products and services, please call
800-996-3428 or visit http://www.globalmedtech.com/,
http://www.peoplemed.com/, http://www.inlog.com/,
http://www.edonor.com/, and http://www.wyndgate.com/. *FDA 510(k)
clearance required prior to sales in the U.S. This news release may
include statements that constitute forward-looking statements,
usually containing the words "believe," "estimate," "project,"
"expects" or similar expressions. These statements are made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements
inherently involve risks and uncertainties that could cause actual
results to differ materially from the forward-looking statements.
By making these forward-looking statements, the Company undertakes
no obligation to update these statements for revisions or changes
after the date of this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: company contact, Michael I. Ruxin, M.D. of Global Med
Technologies, Inc., +1-303-238-2000, ; or investor contact, Paul
Holm, President of portfolio pr, +1-212-888-4570, , for Global Med
Technologies, Inc. Web Site: http://www.globalmedtech.com/
Copyright